[Pharm-policy] March-In Rights
James Love
love@cptech.org
Fri, 11 Aug 2000 13:12:28 -0400
To appreciate how US "March-in Rights" work on patents with US rights on
the legend, see:
http://www4.law.cornell.edu/uscode/35/203.html
http://www4.law.cornell.edu/cfr/45p650.htm
in particular, 650.13
The executive branch is stuck with the statute, but could modify the
regs if it wanted to. But March-in rights can be done without changing
either the statute or the regulations.
Note that US March-in rights apply to the following HIV/AIDS drugs:
ddI
ddC
d4T
Abacavir
Ritonavir
=======================================================
James Love, Director | http://www.cptech.org
Consumer Project on Technology | mailto:love@cptech.org
P.O. Box 19367 | voice: 1.202.387.8030
Washington, DC 20036 | fax: 1.202.234.5176
=======================================================